BCM
GRCL

Brainard Capital Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Brainard Capital Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$48.2K Buy
+25,913
New +$54.2K 0.04% 96

Other funds holding GRCL

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Brainard Capital Management's GRCL Position: Q1 2023 in Review

Brainard Capital Management opened a new position in Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q1 2023: 25,913 shares worth $48.2K. The stake represents 0.04% of the portfolio and ranks #96 among its holdings.

33 funds tracked by Wall St. Rank hold GRCL as of Q1 2023.

  • Brainard Capital Management held 25,913 shares of Gracell Biotechnologies Inc. American Depositary Shares worth $48.2K as of Q1 2023.
  • Gracell Biotechnologies Inc. American Depositary Shares was a new Brainard Capital Management position in Q1 2023.
  • Gracell Biotechnologies Inc. American Depositary Shares made up 0.04% of Brainard Capital Management's portfolio in Q1 2023, its #96 holding.
  • 33 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q1 2023.

Based on Brainard Capital Management's 13F filing for Q1 2023, filed 9 May 2023.